Detalhe da pesquisa
1.
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease.
N Engl J Med
; 386(2): 138-147, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34898140
2.
Betibeglogene Autotemcel Gene Therapy for Non-ß0/ß0 Genotype ß-Thalassemia.
N Engl J Med
; 386(5): 415-427, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34891223
3.
Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells.
Nat Immunol
; 12(2): 167-77, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21217759
4.
Synaptotagmin-mediated vesicle fusion regulates cell migration.
Nat Immunol
; 11(6): 495-502, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473299
5.
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection.
J Gastroenterol Hepatol
; 30(1): 184-91, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995515
6.
Drug product attributes predict clinical efficacy in betibeglogene autotemcel gene therapy for ß-thalassemia.
Mol Ther Methods Clin Dev
; 31: 101155, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38074412
7.
Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.
Proc Natl Acad Sci U S A
; 105(12): 4814-9, 2008 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-18347328
8.
iAIDS: HIV-related internet resources for the practicing clinician.
Clin Infect Dis
; 51(7): 813-22, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20738185
9.
Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
Circ Res
; 102(2): 218-25, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17991878
10.
CXCR3 requires tyrosine sulfation for ligand binding and a second extracellular loop arginine residue for ligand-induced chemotaxis.
Mol Cell Biol
; 26(15): 5838-49, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16847335
11.
Development of a novel chemokine-mediated in vivo T cell recruitment assay.
J Immunol Methods
; 331(1-2): 127-39, 2008 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-18206159
12.
A first-in-human, randomized, double-blind, placebo-controlled, single and multiple ascending oral dose study to assess the safety, tolerability, and pharmacokinetics of BZF961 with and without ritonavir in healthy adult volunteers.
J Drug Assess
; 7(1): 66-74, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370176
13.
Future Directions and Resource Needs for National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Research: A Report of an NHLBI Workshop.
Hum Gene Ther
; 34(3-4): 83-89, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794978
14.
The Safety and Antiviral Activity of BZF961 with or without Ritonavir in Patients Infected with Hepatitis C Virus: A Randomized, Multicenter Trial.
Clin Ther
; 40(9): 1567-1581.e4, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185394
15.
A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial.
ACS Infect Dis
; 3(2): 144-151, 2017 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27788579
16.
Crystal structures of oligomeric forms of the IP-10/CXCL10 chemokine.
Structure
; 11(5): 521-32, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12737818
17.
Movement within and movement beyond: synaptotagmin-mediated vesicle fusion during chemotaxis.
Cell Adh Migr
; 5(1): 56-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-20798599
18.
CXCL10 can inhibit endothelial cell proliferation independently of CXCR3.
PLoS One
; 5(9): e12700, 2010 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20856926
19.
Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.
J Biol Chem
; 284(29): 19189-95, 2009 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-19473985
20.
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36.
J Exp Med
; 206(3): 637-53, 2009 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19237602